EKF Diagnostics Holdings plc provided earnings guidance for the year ending December 31, 2016. The company now expects that it will achieve revenues of at least £36.5 million and adjusted EBITDA of at least £5.5 million, therefore exceeding current market forecasts. The strong performance of the business is due to organic growth. In addition, the company announces that cash generation continues to be strong and now expects to be close to breakeven if not cash positive by the year .